Blinded Independent Central Review (BICR) in New Therapeutic Lung Cancer Trials

Blinded Independent Central Review (BICR) in New Therapeutic Lung Cancer Trials

Background: Double reads in blinded independent central reviews (BICRs) are recommended to control the quality of trials but they are prone to discordances. We analyzed inter-reader discordances in a pool of lung cancer trials using RECIST 1.1. Methods: We analyzed six lung cancer BICR trials that i...

Full description

Bibliographic Details
Main Authors:	Hubert Beaumont, Antoine Iannessi, Yi Wang, Charles M. Voyton, Jennifer Cillario, Yan Liu
Format:	Article
Language:	English
Published:	MDPI AG 2021-09-01
Series:	Cancers
Subjects:	lung cancer clinical trial RECIST 1.1 blinded independent central review
Online Access:	https://www.mdpi.com/2072-6694/13/18/4533

Similar Items

Breaking down the RECIST 1.1 double read variability in lung trials: What do baseline assessments tell us?
by: Antoine Iannessi, et al.
Published: (2023-03-01)

Can we predict discordant RECIST 1.1 evaluations in double read clinical trials?
by: Hubert Beaumont, et al.
Published: (2023-10-01)

RECIST 1.1 and lesion selection: How to deal with ambiguity at baseline?
by: Antoine Iannessi, et al.
Published: (2021-03-01)

Diffusion-weighted MR imaging diagnostic merits in the post-therapeutic assessment of musculoskeletal soft tissue sarcoma
by: Amr Farouk Ibrahim Moustafa, et al.
Published: (2019-11-01)

Immunotherapy Assessment: A New Paradigm for Radiologists
by: Vincenza Granata, et al.
Published: (2023-01-01)

Automatic segmentation of hepatic metastases on DWI images based on a deep learning method: assessment of tumor treatment response according to the RECIST 1.1 criteria
by: Xiang Liu, et al.
Published: (2022-12-01)

The α-RECIST (RECIST 1.1 Combined With Alpha Fetoprotein): A Novel Tool for Identifying Tumor Response of Conversion-Radiotherapy for Unresectable Hepatocellular Carcinoma Before Hepatectomy
by: Ying Xu, et al.
Published: (2022-05-01)

Incorporating lesion-to-lesion heterogeneity into early oncology decision making
by: Rukmini Kumar, et al.
Published: (2023-06-01)

A European Society of Oncologic Imaging (ESOI) survey on the radiological assessment of response to oncologic treatments in clinical practice
by: Giovanni Cappello, et al.
Published: (2023-12-01)

FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma
by: Luke S. McLean, et al.
Published: (2021-10-01)

Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria
by: Roberta Ambrosini, et al.
Published: (2020-05-01)

Underdetermined Blind Separation by Combining Sparsity and Independence of Sources
by: Peng Chen, et al.
Published: (2017-01-01)

Assessment of immunotherapy response in intracranial malignancy using semi-automatic segmentation on magnetic resonance images
by: Jia Tan, et al.
Published: (2022-12-01)

Volumetric CT perfusion assessment of treatment response in head and neck squamous cell carcinoma: Comparison of CT perfusion parameters before and after chemoradiation therapy
by: Lokesh Rana, et al.
Published: (2015-01-01)

Evaluation of liver tumour response by imagingKey points
by: Jules Gregory, et al.
Published: (2020-06-01)

Kappa statistic considerations in evaluating inter-rater reliability between two raters: which, when and context matters
by: Ming Li, et al.
Published: (2023-08-01)

Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy
by: Daphne M. V. Huizing, et al.
Published: (2020-08-01)

Modeling tumor measurement data to predict overall survival (OS) in cancer clinical trials
by: Fang-Shu Ou, et al.
Published: (2021-09-01)

Comparison of RECIST 1.1 and iRECIST in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
by: Hyo Jung Park, et al.
Published: (2021-01-01)

A single‐institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumors
by: Raja Shaikh, et al.
Published: (2023-06-01)

Central bank independence in twelve industrial countries
by: S. EIJFFINGER, et al.
Published: (2013-10-01)

Long Term Efficacy and Assessment of Tumor Response of Transarterial Chemoembolization in Neuroendocrine Liver Metastases: A 15-Year Monocentric Experience
by: Caroline Touloupas, et al.
Published: (2021-10-01)

INTERNALIZATION OF CHILDREN'S INDEPENDENCE VALUE; MANAGEMENT OF ORIENTATION AND MOBILITY PROGRAMS FOR CHILDREN WITH BLIND
by: Eti Suhaeti, et al.
Published: (2021-12-01)

The case for the central bank independence
by: J. DE HAAN, et al.
Published: (2013-10-01)

Blind Source Separation Combining Independent Component Analysis and Beamforming
by: Kurita Satoshi, et al.
Published: (2003-01-01)

BUSCANDO UNA CURVA GENERAL DE RESPUESTA A LA QUIMIOTERAPIA BASADA EN LA EVALUACIÓN RADIOLÓGICA CON CRITERIO RECIST
by: Mauricio Canals L, et al.

Tumor Response Evaluation Using iRECIST: Feasibility and Reliability of Manual Versus Software-Assisted Assessments
by: Inka Ristow, et al.
Published: (2024-02-01)

Are radiologists ready to evaluate true response to immunotherapy?
by: Inci Kizildag Yirgin, et al.
Published: (2021-02-01)

Random guess and wishful thinking are the best blinding scenarios
by: Heejung Bang
Published: (2016-08-01)

Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial: What Can We Learn for Further Phase-II Trials?
by: Eric Thebault, et al.
Published: (2021-04-01)

Defining Clinical Response Criteria and Early Response Criteria for Precision Oncology: Current State-of-the-Art and Future Perspectives
by: Vivek Subbiah, et al.
Published: (2017-02-01)

Central Bank Independence: Where Do We Stand?
by: Osvald Vasicek, et al.
Published: (2023-04-01)

Central bank independence as a prerequisite for ensuring price stability: Modeling the role of the national pattern
by: Atik Kerimov, et al.
Published: (2023-12-01)

Computed Tomography and Spirometry Can Predict Unresectability in Malignant Pleural Mesothelioma
by: Alice Bellini, et al.
Published: (2021-09-01)

Erratum: Tumor response assessment on imaging following immunotherapy
by: Frontiers Production Office
Published: (2023-03-01)

Tumor response assessment on imaging following immunotherapy
by: Antonia M. Berz, et al.
Published: (2022-10-01)

Hybrid Source Prior Based Independent Vector Analysis for Blind Separation of Speech Signals
by: Junaid Bahadar Khan, et al.
Published: (2020-01-01)

CONSORT 2010 and Controversies Regarding Assessment of Blindness in RCTs
by: Norman A. Desbiens, et al.
Published: (2010-11-01)

Constrained Nonnegative Matrix Factorization for Blind Hyperspectral Unmixing Incorporating Endmember Independence
by: E. M. M. B. Ekanayake, et al.
Published: (2021-01-01)

Is institutional effi ciency in independent central banking a communicative matter? Is institutional effi ciency in independent central banking a communicative matter?
by: Tognato Carlo
Published: (2005-08-01)